1171 related articles for article (PubMed ID: 15741570)
1. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.
Shigematsu H; Lin L; Takahashi T; Nomura M; Suzuki M; Wistuba II; Fong KM; Lee H; Toyooka S; Shimizu N; Fujisawa T; Feng Z; Roth JA; Herz J; Minna JD; Gazdar AF
J Natl Cancer Inst; 2005 Mar; 97(5):339-46. PubMed ID: 15741570
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
Shigematsu H; Takahashi T; Nomura M; Majmudar K; Suzuki M; Lee H; Wistuba II; Fong KM; Toyooka S; Shimizu N; Fujisawa T; Minna JD; Gazdar AF
Cancer Res; 2005 Mar; 65(5):1642-6. PubMed ID: 15753357
[TBL] [Abstract][Full Text] [Related]
3. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T
Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253
[TBL] [Abstract][Full Text] [Related]
5. [Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].
Pan ZK; Zhang L; Zhang X; Wang X; Li N; Xu F; Chang JH; Guan ZZ
Ai Zheng; 2005 Aug; 24(8):919-23. PubMed ID: 16086866
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor expression status in lung cancer correlates with its mutation.
Suzuki M; Shigematsu H; Hiroshima K; Iizasa T; Nakatani Y; Minna JD; Gazdar AF; Fujisawa T
Hum Pathol; 2005 Oct; 36(10):1127-34. PubMed ID: 16226114
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient population.
Liam CK; Leow HR; How SH; Pang YK; Chua KT; Lim BK; Lai NL; Kuan YC; Pailoor J; Rajadurai P
Asian Pac J Cancer Prev; 2014; 15(1):321-6. PubMed ID: 24528049
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
[TBL] [Abstract][Full Text] [Related]
11. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system].
Zhang J; Liang ZY; Zeng X; Wu SF; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Chen LF; Chen XY; Yu XB
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
[TBL] [Abstract][Full Text] [Related]
13. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
[TBL] [Abstract][Full Text] [Related]
14. Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Taron M; Ichinose Y; Rosell R; Mok T; Massuti B; Zamora L; Mate JL; Manegold C; Ono M; Queralt C; Jahan T; Sanchez JJ; Sanchez-Ronco M; Hsue V; Jablons D; Sanchez JM; Moran T
Clin Cancer Res; 2005 Aug; 11(16):5878-85. PubMed ID: 16115929
[TBL] [Abstract][Full Text] [Related]
15. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.
Pao W; Miller V; Zakowski M; Doherty J; Politi K; Sarkaria I; Singh B; Heelan R; Rusch V; Fulton L; Mardis E; Kupfer D; Wilson R; Kris M; Varmus H
Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13306-11. PubMed ID: 15329413
[TBL] [Abstract][Full Text] [Related]
16. [Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].
Yang CS; Pan XY; Feng Q; Wang YY; Xu WM; Jiang T; Wang L; Yang JL; Wang L
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):226-30. PubMed ID: 27033384
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
Tsao AS; Tang XM; Sabloff B; Xiao L; Shigematsu H; Roth J; Spitz M; Hong WK; Gazdar A; Wistuba I
J Thorac Oncol; 2006 Mar; 1(3):231-9. PubMed ID: 17409862
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
Murray S; Timotheadou E; Linardou H; Vrettou AV; Kostopoulos I; Skrickova J; Papakostantinou C; Christodoulou C; Pectasides D; Samantas E; Papakostas P; Skarlos DV; Kosmidis P; Fountzilas G
Lung Cancer; 2006 May; 52(2):225-33. PubMed ID: 16567021
[TBL] [Abstract][Full Text] [Related]
19. [EGFR gene mutation status among lung cancer patients in China].
Li Q; Zhao YL; Hao HJ; Li XH
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):270-3. PubMed ID: 17760253
[TBL] [Abstract][Full Text] [Related]
20. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]